NexGen Press

To respond to present and future market demands, manufacturers are looking for flexible and multifunctional solutions that can handle both low and high potency active ingredients. This next generation of modular tablet presses will make machine selection easier, facilitate fast product changeovers and deliver price-performance leadership. Offering operational excellence, each NexGen Press® is intuitive, simple to use and benefits from a back-to-basics design philosophy. And, of course, like any GEA press, safety, robust functionality, support and customer service come as standard.

After the introduction of the first size in the range at Achema 2022, NexGen Press® 30, this year's Achema will see the unveiling of the NexGen Press® 45, offering higher throughputs, while maintaining all the flexibility that was designed into the NexGen Press® 30.

Request your ticket here!

Available in two formats the CE-certified NexGen Press® GMP features a dust-tight enclosure for easy handling. If required, with the addition of lay flats and pressure monitoring, the GMP option can be upgraded for OEB 3 containment applications.

For example, an entry level machine can be upgraded to meet specific process requirements, such as bilayer tableting, different washing options and/or to further reduce the risk of cross-contamination, as and when required.

The NexGen Press® OEB offers both OEB 4 and 5 containment functionality and can be equipped with the BUCK® Digital Canary for real-time monitoring and/or the BUCK® (U)MC valve for contained loading.

Featuring a reduced-volume and isolated product contact area, the “double barrier” will increase operator safety. Being easier and faster to clean will mean shorter production changeovers and less downtime. The contained turret allows for a replacement to be installed in less than 1 hour. And, in an increasingly connected working environment, the presses are Industry 4.0-compatible and digitalized. 

Designed to accommodate a wide range of functionalities, from general GMP production to high-containment applications, GEA has once again applied its experience and knowledge to serve the current and future pharmaceutical workforce, and the patients who depend on their products.

Furthermore, the NexGen Press® range is fully compatible with GEA’s new Digital Canary monitoring system, which both detects product leaks from contained pharmaceutical production lines and protects the health and safety of your operators.

Offering a number of plug-and-play options for applications including orodispersible, MUPS and bilayer tablets, the NexGen Press® also benefits from a user-friendly HMI with multitouch functionality, interactive digital manuals and online project documents. 

To meet the rigorous standards of ISO 14021 and adhere to the defined criteria set by TÜV Rheinland, the NexGen Press® 30 underwent external audits, emerging as a deserving recipient of GEA's Add Better label.* This label is a testament to GEA's dedication to providing solutions that are not just better but significantly superior to their predecessors.

To evaluate the energy-saving potential of NexGen Press® 30, we conducted extensive testing, comparing the machine's total power consumption at the 3-phase power supply inlet to GEA's previous range of tablet presses.  

On average, NexGen Press® 30 achieved a remarkable 21% reduction in power consumption compared to its predecessors.

* The Add Better label relates to the serial product GEA NexGen Press® 30, released in August 2022.